David P Tuck MD

Voluntary Clinical Associate Professor, Hematology & Medical Oncology

820 Harrison Ave | (781) 491-4214
DT
Sections

Hematology & Medical Oncology

Education

MD, University of Vermont College of Medicine, 1985

Psychology, AB, Harvard College, 1974

Publications

Published on 3/26/2022

Cheng D, Dumontier C, Sheikh AR, La J, Brophy MT, Do NV, Driver JA, Tuck DP, Fillmore NR. Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer. Cancer Med. 2022 Aug; 11(15):3009-3022. PMID: 35338613.

Published on 3/1/2022

Katabathula R, Joseph P, Singh S, Zhao S, Kumar B, Gaule P, Pan Q, Old M, Tuck DP, Varadan V. Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer. Clin Cancer Res. 2022 03 01; 28(5):984-992. PMID: 34785584.

Published on 2/14/2022

Tuck D. A cancer graph: a lung cancer property graph database in Neo4j. BMC Res Notes. 2022 Feb 14; 15(1):45. PMID: 35164854.

Published on 2/1/2022

Wu JT, La J, Branch-Elliman W, Huhmann LB, Han SS, Parmigiani G, Tuck DP, Brophy MT, Do NV, Lin AY, Munshi NC, Fillmore NR. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study. JAMA Oncol. 2022 02 01; 8(2):281-286. PMID: 34854921.

Published on 11/16/2021

Erbe R, Wang Z, Wu S, Xiu J, Zaidi N, La J, Tuck D, Fillmore N, Giraldo NA, Topper M, Baylin S, Lippman M, Isaacs C, Basho R, Serebriiskii I, Lenz HJ, Astsaturov I, Marshall J, Taverna J, Lee J, Jaffee EM, Roussos Torres ET, Weeraratna A, Easwaran H, Fertig EJ. Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Rep. 2021 Nov 16; 37(7):110033. PMID: 34788629.

Published on 8/24/2021

Erbe R, Wang Z, Wu S, Xiu J, Zaidi N, La J, Tuck D, Fillmore N, Giraldo NA, Topper M, Baylin S, Lippman M, Isaacs C, Basho R, Serebriiskii I, Lenz HJ, Astsaturov I, Marshall J, Taverna J, Lee J, Jaffee EM, Roussos Torres ET, Weeraratna A, Easwaran H, Fertig EJ. Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Rep. 2021 08 24; 36(8):109599. PMID: 34433020.

Published on 6/1/2021

Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, Do NV, Brophy MT, Munshi NC. Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study. J Natl Cancer Inst. 2021 06 01; 113(6):691-698. PMID: 33031532.

Published on 10/1/2020

La J, Cheng D, Brophy MT, Do NV, Lee JSH, Tuck D, Fillmore NR. Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System. JCO Clin Cancer Inform. 2020 10; 4:918-928. PMID: 33074743.

Published on 10/30/2019

Cheng D, Ramos-Cejudo J, Tuck D, Elbers D, Brophy M, Do N, Fillmore N. External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data Commons. Semin Oncol. 2019 Aug - Oct; 46(4-5):327-333. PMID: 31708233.

Published on 10/2/2019

Do N, Grossman R, Feldman T, Fillmore N, Elbers D, Tuck D, Dhond R, Selva L, Meng F, Fitzsimons M, Ajjarapu S, Ayandeh S, Hall R, Do S, Brophy M. The Veterans Precision Oncology Data Commons: Transforming VA data into a national resource for research in precision oncology. Semin Oncol. 2019 Aug - Oct; 46(4-5):314-320. PMID: 31629530.

View full list of 73 publications.